Plasma antioxidants are associated with impaired lung function and COPD exacerbations in smokers

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 8, Issue 4, 2011, Pages 264-269

  Nicks, Michael E ^a   O'Brien, Maureen M ^b   Bowler, Russell P ^a  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Antioxidants; COPD; Exacerbation; Glutathione; Plasma; Uric acid

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; GLUTATHIONE; URIC ACID;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DIETARY INTAKE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HUMAN; LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PLASMA; PRIORITY JOURNAL; SPIROMETRY;

AGED; ANTIOXIDANTS; ASCORBIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORADO; COLORIMETRY; CROSS-SECTIONAL STUDIES; FEMALE; GLUTATHIONE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SMOKING; URIC ACID;

EID: 80052066554     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2011.579202     Document Type: Article

References (49)

1. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: A 25 year follow up study of the general population. Torax 2006; 61(11):935-939. (Pubitemid 44787161)
2. Bowler RP, Barnes PJ, Crapo JD. Te role of oxidative stress in chronic obstructive pulmonary disease. COPD 2004; 1(2): 255-277.
3. Mroz RM, Holownia A, Chyczewska E, Drost EM, Braszko JJ, Noparlik J, Donaldson K, Macnee W. Cytoplasm-nuclear trafck-ing of CREB and CREB phosphorylation at Ser133 during therapy of chronic obstructive pulmonary disease. J Physiol Pharmacol 2007; 58 Suppl 5(Pt 2):437-44. (Pubitemid 351346692)
4. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. Te nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(26):2645-2653. (Pubitemid 38787999)
5. Hageman GJ, Larik I, Pennings HJ, Haenen GR, Wouters EF, Bast A. Systemic poly(ADP-ribose) polymerase-1 activation, chronic infammation, and oxidative stress in COPD patients. Free Radic Biol Med 2003; 35(2):140-148. (Pubitemid 36835914)
6. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Torac Soc 2005; 2(1):50-60. (Pubitemid 40562963)
7. Tabak C, Smit HA, Rasanen L, Fidanza F, Menotti A, Nissi-nen A, Feskens EJ, Heederik D, Kromhout D. Dietary factors and pulmonary function: a cross sectional study in middle aged men from three European countries. Torax 1999; 54(11):1021-1026. (Pubitemid 29495398)
8. Walda IC, Tabak C, Smit HA, Rasanen L, Fidanza F, Menotti A, Nissinen A, Feskens EJ, Kromhout D. Diet and 20-year chronic obstructive pulmonary disease mortality in middle-aged men from three European countries. Eur J Clin Nutr 2002; 56(7)638-643. (Pubitemid 34822903)
9. Grievink L, Smit HA, Ocke MC, van 't Veer P, Kromhout D. Dietary intake of antioxidant (pro)-vitamins, respiratory symptoms andpulmonaryfunction: Te MORGEN study. Torax 1998; 53(3):166-171. (Pubitemid 28172365)
10. Romieu I, Trenga C. Diet and obstructive lung diseases. Epidemiol Rev 2001; 23(2):268-287.
11. Garcia-Pachon E, Padilla-Navas I, Shum C. Serum uric acid to cre-atinine ratio in patients with chronic obstructive pulmonary disease. Lung 2007; 185(1):21-24. (Pubitemid 46295103)
12. Gosker HR, Bast A, Haenen GR, Fischer MA, Van Der Vusse GJ, Wouters EF, Schols AM. Altered antioxidant status in peripheral skeletal muscle of patients with COPD. Respir Med 2005; 99(1):118-125. (Pubitemid 40017395)
13. Liu CS, Chen HW, Lii CK, Chen SC, Wei YH. Alterations of small-molecular-weight antioxidants in the blood of smokers. Chem Biol Interact 1998; 116(1-2):143-154. (Pubitemid 29023159)
14. Premanand R, Kumar S, Mohan A. Study of thiobarbituric reactive substances and total reduced glutathione as indices of oxidative stress in chronic smokers with and without chronic obstructive pulmonary disease. Ind J Chest Dis Allied Sci 2007; 49(1):9-12.
15. Van Helvoort HA, Heijdra YF, Tijs HW, Vina J, Wanten GJ, Dekhuijzen PN. Exercise-induced systemic efects in muscle-wasted patients with COPD. Med Sci Sports Exerc 2006; 38(9):1543-1152.
16. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine; 4th ed. Oxford University Press; New York; 2007:xxxvi, 851 p. [8] p. of plates.
17. Lopez IH. Serum Uric Acid Levels Among Patients With Chronic Obstructive Pulmonary Disease Chest Meeting Abstracts 2003; 124:168S-a.
18. Van Der Vliet A, O'Neill CA, Cross CE, Koostra JM, Volz WG, Halliwell B, Louie S. Determination of low-molecular-mass an-tioxidant concentrations in human respiratory tract lining fuids. Am J Physiol 1999; 276(2 Pt 1):L289-296. (Pubitemid 29102270)
19. Kinnula VL, Vuorinen K, Ilumets H, Rytila P, Myllarniemi M. Tiol proteins, redox modulation and parenchymal lung disease. Curr Med Chem 2007; 14(2):213-222. (Pubitemid 46043916)
20. Kelly FJ. Gluthathione: In defence of the lung. Food Chem Toxicol 1999; 37(9-10):963-966. (Pubitemid 29481798)
21. Halliwell B, Gutteridge M. Free Radicals in Biology and Medicine; 3rd ed. Oxford University Press, New York; 2000.
22. Abuja PM. Ascorbate prevents prooxidant efects of urate in oxidation of human low density lipoprotein. FEBS Lett 1999; 446(2-3):305-308. (Pubitemid 29132748)
23. Ochs-Balcom HM, Grant BJ, Muti P, Sempos CT, Freudenheim JL, Browne RW, McCann SE, Trevisan M, Cassano PA, Iacoviello L, Schunemann HJ. Antioxidants, oxidative stress, and pulmonary function in individuals diagnosed with asthma or COPD. Eur J Clin Nutr 2006; 60(8):991-999. (Pubitemid 44161021)
24. Sutherland ER, Crapo JD, Bowler RP. N-acetylcysteine and exacerbations of chronic obstructive pulmonary disease. COPD 2006; 3(4):195-202. (Pubitemid 44949059)
25. Decramer M, Rutten-van Molken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R, van Schayck CP, Olivieri D, Del Donno M, De Backer W, Lankhorst I, Ardia A. Efects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): A randomised placebo-controlled trial. Lancet 2005; 365(9470):1552-1560. (Pubitemid 40615404)
26. Fabbri LM, Hurd SS. Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Respir J 2003; 22(1):1-2. (Pubitemid 36896461)
27. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159(1):179-187. (Pubitemid 29036522)
28. MacNee W. Oxidants and COPD. Curr Drug Targets Infamm Allergy 2005; 4(6):627-641. (Pubitemid 41722373)
29. MacNee W. Oxidants/antioxidants and COPD. Chest 2000; 117(5 Suppl 1):303S-317S. (Pubitemid 30327005)
30. Tsuchiya M, Asada A, Kasahara E, Sato EF, Shindo M, Inoue M. Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma. Circulation 2002; 105(10):1155-1157. (Pubitemid 34225813)
31. Rahman I, MacNee W. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am J Phys-iol 1999; 277(6 Pt 1):L1067-1088. (Pubitemid 30046033)
32. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: A hypothesis. Proc Natl Acad Sci USA 1981; 78(11):6858-6862. (Pubitemid 12216861)
33. Whiteman M, Ketsawatsakul U, Halliwell B. A reassessment of the peroxynitrite scavenging activity of uric acid. Ann NY Acad Sci 2002; 962:242-259. (Pubitemid 34592316)
34. Calikoglu M, Unlu A, Tamer L, Ercan B, Bugdayci R, Atik U. Te levels of serum vitamin C, malonyldialdehyde and erythrocyte reduced glutathione in chronic obstructive pulmonary disease and in healthy smokers. Clin Chem Lab Med 2002; 40(10):1028-1031. (Pubitemid 35356021)
35. Tkacova R, Kluchova Z, Joppa P, Petrasova D, Molcanyiova A. Systemic infammation and systemic oxidative stress in patients with acute exacerbations of COPD. Respir Med 2007; 101(8):1670-1676. (Pubitemid 46930714)
36. Sadowska AM, van Overveld FJ, Gorecka D, Zdral A, Filewska M, Demkow UA, Luyten C, Saenen E, Zielinski J, De Backer WA. Te interrelationship between markers of infammation and oxidative stress in chronic obstructive pulmonary disease: modulation by inhaled steroids and antioxidant. Respir Med 2005; 99(2):241-249. (Pubitemid 40104281)
37. Drost EM, Skwarski KM, Sauleda J, Soler N, Roca J, Agusti A, MacNee W. Oxidative stress and airway infammation in severe exacerbations of COPD. Torax 2005; 60(4):293-300. (Pubitemid 40522365)
38. Morrison D, Rahman I, Lannan S, MacNee W. Epithelial permeability, infammation, and oxidant stress in the air spaces of smokers. Am J Respir Crit Care Med 1999; 159(2): 473-479. (Pubitemid 29084868)
39. Beeh KM, Beier J, Koppenhoefer N, Buhl R. Increased glutathione disulfde and nitrosothiols in sputum supernatant of patients with stable COPD. Chest 2004; 126(4):1116-1122. (Pubitemid 39391240)
40. Groenewegen KH, Dentener MA, Wouters EF. Longitudinal follow-up of systemic infammation afer acute exacerbations of COPD. Respir Med 2007; 101(11):2409-2415. (Pubitemid 47471393)
41. Jones DP, Carlson JL, Samiec PS, Sternberg Jr. P, Mody Jr. VC, Reed RL, Brown LA. Glutathione measurement in human plasma. Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin Chim Acta 1998; 275(2):175-184. (Pubitemid 28323074)
42. Samiec PS, Drews-Botsch C, Flagg EW, Kurtz JC, Sternberg Jr P, Reed RL, Jones DP. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med 1998; 24(5):699-704. (Pubitemid 28169555)
43. Moriarty SE, Shah JH, Lynn M, Jiang S, Openo K, Jones DP, Sternberg P. Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radic Biol Med, 2003; 35(12):1582-1588. (Pubitemid 37532909)
44. Tug T, Karatas F, Terzi SM. Antioxidant vitamins (A, C and E) and malondialdehyde levels in acute exacerbation and stable periods of patients with chronic obstructive pulmonary disease. Clin Invest Med 2004;27(3):123-128. (Pubitemid 39233772)
45. Linster CL, Van Schafingen E. Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J 2007; 274(1): p. 1-22.
46. Jones DP, Coates RJ, Flagg EW, Eley JW, Block G, Greenberg RS, Gunter EW, Jackson B. Glutathione in foods listed in the National Cancer Institute's Health Habits and History Food Frequency Questionnaire. Nutr Cancer 1992; 17(1):57-75.
47. Wright ME, Park Y, Subar AF, Freedman ND, Albanes D, Hol-lenbeck A, Leitzmann MF, Schatzkin A. Intakes of fruit, vegetables, and specifc botanical groups in relation to lung cancer risk in the NIH-AARP Diet and Health Study. Am J Epidemiol 2008; 168(9):1024-1034.
48. Sadowska AM, Manuel YKB, De Backer WA. Antioxidant and anti-infammatory efcacy of NAC in the treatment of COPD: Discordant in vitro and in vivo dose-efects: a review. Pulm Pharmacol Ter 2007; 20(1):9-22. (Pubitemid 44648802)
49. Nelson SK, Bose SK, Grunwald, GK, Myhill P, McCord JM. Te induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to an-tioxidant therapy. Free Radic Biol Med 2006; 40(2):341-347. (Pubitemid 43069358)